Search

Your search keyword '"Poh, Zhi Sheng"' showing total 11 results
Start Over Author "Poh, Zhi Sheng"
11 results on '"Poh, Zhi Sheng"'

4. High Extracellular K+ Drives T-Cell Exhaustion by Disrupting TCR Signals Implicated in Tumor Immune Evasion

Author

Wong, Brandon Han Siang, primary, Poh, Zhi Sheng, additional, Wei, James Tan Chia, additional, Amuthavalli, Kottaiswamy, additional, Ho, Ying Swan, additional, Chen, Shuwen, additional, Mak, Shi Ya, additional, Bi, Xuezhi, additional, Webster, Richard, additional, Shelat, Vishalkumar, additional, Chandy, K. George, additional, and Verma, Navin Kumar, additional

Published
2024
Full Text
View/download PDF

5. DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes

Author

Kizhakeyil, Atish, Zaini, Nurmahirah Binte Mohammed, Poh, Zhi Sheng, Wong, Brandon Han Siang, Loh, Xinpeng, Ng, Aik Seng, Low, Zun Siong, Prasannan, Praseetha, Gong, Chun, Tan, Michelle Guet Khim, Nagarajan, Chandramouli, Huang, Dachuan, Lu, Pang Wan, Lim, Jing Quan, Barrans, Sharon, Ong, Choon Kiat, Lim, Soon Thye, Chng, Wee Joo, Follows, George, Hodson, Daniel J., Du, Ming Qing, Goh, Yeow Tee, Tan, Suat Hoon, Grigoropoulos, Nicholas Francis, and Verma, Navin Kumar

Published
2021
Full Text
View/download PDF

7. Electrospun Aligned PCL/Gelatin Scaffolds Mimicking the Skin ECM for Effective Antimicrobial Wound Dressings

Author

Ghomi, Erfan Rezvani, primary, Lakshminarayanan, Rajamani, additional, Chellappan, Vijila, additional, Verma, Navin Kumar, additional, Chinnappan, Amutha, additional, Neisiany, Rasoul Esmaeely, additional, Amuthavalli, Kottaiswamy, additional, Poh, Zhi Sheng, additional, Wong, Brandon Han Siang, additional, Dubey, Nileshkumar, additional, Narayan, Roger, additional, and Ramakrishna, Seeram, additional

Published
2022
Full Text
View/download PDF

8. ZAKα-driven ribotoxic stress response activates the human NLRP1 inflammasome

Author

Robinson, Kim S., primary, Toh, Gee Ann, additional, Rozario, Pritisha, additional, Chua, Rae, additional, Bauernfried, Stefan, additional, Sun, Zijin, additional, Firdaus, Muhammad Jasrie, additional, Bayat, Shima, additional, Nadkarni, Rhea, additional, Poh, Zhi Sheng, additional, Tham, Khek Chian, additional, Harapas, Cassandra R., additional, Lim, Chrissie K., additional, Chu, Werncui, additional, Tay, Celest W. S., additional, Tan, Kiat Yi, additional, Zhao, Tianyun, additional, Bonnard, Carine, additional, Sobota, Radoslaw, additional, Connolly, John E., additional, Common, John, additional, Masters, Seth L., additional, Chen, Kaiwen W., additional, Ho, Lena, additional, Wu, Bin, additional, Hornung, Veit, additional, and Zhong, Franklin L., additional

Published
2022
Full Text
View/download PDF

10. DDX3X Loss is Associated with Aggressive Phenotypes in Non-Hodgkin’s Lymphomas

Author

Kizhakeyil, Atish, primary, Zaini, Nurmahirah binte Mohammed, additional, Poh, Zhi Sheng, additional, Wong, Brandon Han Siang, additional, Loh, Xinpeng, additional, Ng, Aik Seng, additional, Low, Zun Siong, additional, Prasannan, Praseetha, additional, Gong, Jade, additional, Tan, Michelle Guet Khim, additional, Nagarajan, Chandramouli, additional, DaChuan, Huang, additional, Lu, Pang Wang, additional, Lim, Jing Quan, additional, Barrans, Sharon, additional, Ong, Choon Kiat, additional, LIM, Soon Thye, additional, Chng, Wee Joo, additional, Follows, George, additional, Hodson, Daniel, additional, Du, Ming-Qing, additional, Goh, Yeow Tee, additional, Tan, Suat Hoon, additional, Grigoropoulos, Nicholas, additional, and Verma, Navin Kumar, additional

Published
2021
Full Text
View/download PDF

11. DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes

Author

Kizhakeyil, Atish, Zaini, Nurmahirah Binte Mohammed, Poh, Zhi Sheng, Wong, Brandon Han Siang, Loh, Xinpeng, Ng, Aik Seng, Low, Zun Siong, Prasannan, Praseetha, Gong, Chun, Tan, Michelle Guet Khim, Nagarajan, Chandramouli, Huang, Dachuan, Lu, Pang Wan, Lim, Jing Quan, Barrans, Sharon, Ong, Choon Kiat, Lim, Soon Thye, Chng, Wee Joo, Follows, George, Hodson, Daniel J, Du, Ming Qing, Goh, Yeow Tee, Tan, Suat Hoon, Grigoropoulos, Nicholas Francis, and Verma, Navin Kumar

Subjects
STAT3 Transcription Factor, Tumour metastasis, Lymphoma, Non-Hodgkin, Antineoplastic Agents, Prognosis, Hematolymphoid malignancy, 3. Good health, DEAD-box RNA Helicases, immune system diseases, Drug Resistance, Neoplasm, hemic and lymphatic diseases, Drug resistance, Cell Line, Tumor, Mutation, Exome Sequencing, Biomarkers, Tumor, Disease Progression, Humans, Cyclin D1, DDX3X mutation, Lymphoma, Large B-Cell, Diffuse, Mitogen-Activated Protein Kinases
Abstract

Non-Hodgkin a diverse group of malignancies, encompassing the common difuse large B-cell lymphoma (DLBCL) to the rarer T-cell lymphomas. Chemoresistance is a major barrier to treatment and the mechanisms through which it occurs are incompletely understood [1]. Although eforts are made to target frequently dysregulated pathways in NHL subtypes, these diseases still evolve into aggressive forms resistant even to newer therapies [2].

Catalog

Books, media, physical & digital resources
See catalog results